An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Asenapine (Primary) ; Serotonin uptake inhibitors
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 12 Oct 2016 Status changed from recruiting to completed.
- 01 Dec 2014 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov record.
- 26 Nov 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.